Embecta Corp (NAS:EMBC)

$ 14.97 0.43 (2.96%) Market Cap: 863.80 Mil Enterprise Value: 2.20 Bil PE Ratio: 12.48 PB Ratio: 0 GF Score: 28/100

Q3 2024 Embecta Corp Earnings Call Transcript
Aug 09, 2024

$15.39 (+7.32%)

Earnings
Q1 2024 Embecta Corp Earnings Call Transcript
Feb 09, 2024

$16.26 (-8.47%)

Earnings
Embecta Corp at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q4 2023 Embecta Corp Earnings Call Transcript
Nov 21, 2023

$17.06 (+4.47%)

Earnings
Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q3 2023 Embecta Corp Earnings Call Transcript
Aug 08, 2023

$22.17 (+2.59%)

Earnings
Embecta Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023
Q2 2023 Embecta Corp Earnings Call Transcript
May 12, 2023

$30.69 (+6.12%)

Earnings
Q1 2023 Embecta Corp Earnings Call Transcript
Feb 14, 2023

$32 (+12.56%)

Earnings
Embecta Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q4 2022 Embecta Corp Earnings Call Transcript
Dec 20, 2022

$27.4 (-15.64%)

Earnings
Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Embecta Corp at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022
Q3 2022 Embecta Corp Earnings Call Transcript
Aug 15, 2022

$33.42 (+16.53%)

Earnings
Q2 2022 Embecta Corp Earnings Call Transcript
May 13, 2022

$26.33 (-8.83%)

Earnings

Q3 2022 Embecta Corp Earnings Call Transcript

Aug 15, 2022 / 12:00PM GMT

Release Date Price: $33.42 (+16.53%)

Transcript 10-Q8-K

Operator

Welcome, ladies and gentlemen, to the Third Quarter Fiscal Year 2022 Earnings Conference Call for Embecta Corp.

(Operator Instructions)

Please note that this conference call is being recorded, and that recorded will be available on the company's website for replay shortly. I would now like to hand the conference over to your speaker today, Mr. Pravesh Khandelwal, Vice President of Investor Relations. Please go ahead.

Pravesh Khandelwal

Thank you, operator. Good morning, everyone. Thank you for joining our fiscal third quarter 2022 earnings call. With me today are Dev Kurdikar, Embecta's Chief Executive Officer; and Jake Elguicze, our Chief Financial Officer. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements within the meaning of the federal securities laws which may be identified by words like anticipate, expect, may, believe, estimate and other similar words. And it is possible actual results could differ from management's

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.